Zuellig Pharma Korea to face bumpy road

Published: 2010-03-30 06:59:00

Updated: 2010-03-30 06:59:00

The market dominance of Zuellig Pharma Korea in the local wholesaling industry might be weakened as a number of multinational drug manufacturers are considering making direct transactions with pharmaceutical wholesalers to boost the revenues for specific items, according to market insiders.

On...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK